Status:
UNKNOWN
A Comparison Between D1 and D2 Lymphadenectomy in Gastric Cancer : A Prospective Randomized Controlled Trial
Lead Sponsor:
Tata Memorial Hospital
Conditions:
Gastric Cancer
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Gastric cancer remains the second most common cancer worldwide.Although the prognosis is poor for majority of patients , long term survival is achievable in patients in whom surgical resection is poss...
Eligibility Criteria
Inclusion
- Patients with biopsy/frozen section proven adenocarcinoma of stomach.
- Preoperative clinical examination and imaging indicating operable disease.
- Intraoperative exploration indicating operability i.e. no peritoneal deposits,no evidence of para aortic lymphadenopathy,no direct involvement of contiguous organs
- Surgical plan for distal/proximal/total gastrectomy
Exclusion
- Patients with low performance score
- Staging investigations or intraoperative exploration indicating inoperable disease
- Patients medically unfit for major surgery
- Patients who have been given preoperative chemotherapy/chemoradiation.
- Patients with gastroesophageal junction tumours
- Patients unreliable for follow up
- Patients above the age of 70 years
- Past history of malignancy
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
End Date :
March 1 2014
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00447746
Start Date
March 1 2007
End Date
March 1 2014
Last Update
March 15 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tata Memorial Hospital,Tata Memorial Centre
Mumbai, Maharashtra, India, 400012